Here are 1-3 brief analogies for Dentsply Sirona:

• GE Healthcare for dentistry
• Stryker for dental professionals
• The Apple of dental technology

• Digital Imaging Systems: Provides X-ray machines, intraoral cameras, and 3D cone beam computed tomography (CBCT) systems for comprehensive dental diagnostics and treatment planning.
• CAD/CAM Systems: Offers integrated hardware and software solutions, such as CEREC, enabling dentists to design, mill, and place dental restorations like crowns and veneers in a single visit.
• Treatment Centers & Instruments: Manufactures dental chairs, integrated delivery systems, and a wide array of handheld instruments essential for various dental procedures.
• Restorative Materials: Supplies a broad range of composites, bonding agents, ceramics, and other materials used for direct and indirect dental fillings, crowns, and bridges.
• Dental Implants: Delivers complete systems for tooth replacement, encompassing implants, abutments, and surgical kits for effective osseointegration.
• Endodontic Products: Provides specialized instruments and materials, including files, sealers, and obturators, vital for successful root canal treatments.
• Orthodontic Solutions: Offers clear aligner systems (SureSmile), traditional brackets, wires, and other products designed for effective tooth alignment and bite correction.
• Preventive & Prophylaxis Products: Produces professional dental cleaning tools, fluoride treatments, and sealants aimed at promoting long-term oral health and preventing dental issues.

• Dental Distributors: These companies purchase Dentsply Sirona's products in bulk and then resell them to individual dental practices, laboratories, and specialists globally. Major public company customers in this category include:
  • Henry Schein, Inc. (symbol: HSIC)
  • Patterson Companies Inc. (symbol: PDCO)
• Dental Service Organizations (DSOs): These are management companies that own or manage groups of dental practices. DSOs often centralize their purchasing decisions, making them significant customers for dental suppliers like Dentsply Sirona. Many DSOs are privately held.
• Institutional Buyers: This category includes dental schools, universities, hospitals, and government health agencies that equip their facilities with dental technology, equipment, and consumables.

null

Daniel Scavilla, President and Chief Executive Officer

Daniel Scavilla was appointed President and Chief Executive Officer of Dentsply Sirona, effective August 1, 2025. He brings over three decades of experience in the medical technology and pharmaceutical industries. Prior to joining Dentsply Sirona, Mr. Scavilla served as President and CEO of Globus Medical, where he oversaw the acquisition of NuVasive and the subsequent integration of the two organizations, forming the world's second-largest spine technology company. His roles at Globus Medical also included Chief Financial Officer, Executive Vice President, Chief Commercial Officer, and President of Trauma, during which he expanded manufacturing and distribution operations and launched the orthopedics and trauma division. Before Globus Medical, he spent 28 years in various financial and operational leadership positions at Johnson & Johnson.

Matthew E. Garth, Executive Vice President and Chief Financial Officer

Matthew E. Garth was named Executive Vice President and Chief Financial Officer for Dentsply Sirona, effective May 30, 2025. He possesses nearly 30 years of experience in financial leadership and strategic transformation across several multinational corporations. Before joining Dentsply Sirona, Mr. Garth was the Chief Financial Officer and Chief Administrative Officer at The Scotts Miracle-Gro Company, where he contributed to stabilizing the business after the pandemic and developing long-term strategic plans. His career also includes senior financial leadership roles at Minerals Technologies Inc., where he held global responsibility for finance, tax, treasury, audit, investor relations, information technology, and shared services, and at Alcoa Corp., where he served as CFO for two multi-billion-dollar business units. Mr. Garth began his career at Thomson Financial. He holds a Bachelor of Science in Accounting from the University of Delaware and an MBA from Columbia University.

Andreas Frank, Executive Vice President, Chief Business Officer

Andreas Frank serves as Executive Vice President, Chief Business Officer at Dentsply Sirona. No detailed background is available in the provided search results.

Andrea Frohning, Senior Vice President & Chief Human Resources Officer

Andrea Frohning is the Senior Vice President & Chief Human Resources Officer at Dentsply Sirona. No detailed background is available in the provided search results.

Kevin Boyle, Senior Vice President & Chief Technology Officer

Kevin Boyle holds the position of Senior Vice President & Chief Technology Officer at Dentsply Sirona. No detailed background is available in the provided search results.

1. Weakened Demand, Competitive Pressures, and Operational Underperformance in Key Markets: The company has experienced weakened demand and significant competitive pressures, particularly in its U.S. implants business and equipment sales, leading to substantial non-cash impairment charges for goodwill and other intangible assets in 2024. This underperformance in critical markets, especially the U.S., is a major focus for management's "Return-to-Growth" action plan.
2. Cybersecurity Incidents: Dentsply Sirona relies heavily on information and technology for its operations and product portfolios. Any cyber incidents could significantly harm its operations, lead to intellectual property theft, expose it to fraud or extortion, result in harm to employees or customers, cause violations of privacy laws or other regulatory and compliance lapses, damage its reputation, and impact its ability to consistently deliver digital business solutions.
3. Regulatory and Compliance Risks: As a manufacturer of professional dental products and technologies, the majority of Dentsply Sirona's products are classified as medical devices. This subjects the company to extensive restrictions under domestic and foreign laws, rules, regulations, and self-regulatory codes, including but not limited to the U.S. Food, Drug, and Cosmetic Act and the EU's Medical Devices Directive. Non-compliance with these regulations could lead to penalties and impact business operations.

Dentsply Sirona operates in several significant addressable markets within the dental industry. The estimated market sizes for their main products and services globally are as follows:

• Dental Equipment: The global dental equipment market was valued at approximately USD 11.95 billion in 2024 and is projected to reach around USD 22.1 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 6.34% from 2025 to 2034. North America held the largest share of the dental equipment market in 2023.
• Dental Consumables: The global dental consumables market size was estimated at USD 36.37 billion in 2024 and is projected to reach USD 73.46 billion by 2033, growing at a CAGR of 8.17% from 2025 to 2033. North America dominated the global industry with the largest revenue share of 47.54% in 2024.
• Dental Implants: The global dental implants market size was valued at USD 6.8 billion in 2024 and is estimated to reach USD 9.8 billion by 2033, demonstrating a CAGR of 4.16% from 2025 to 2033. North America currently dominates this market, holding a share of over 36.8% in 2024.
• Clear Aligners: The global clear aligners market size is calculated at USD 6.51 billion in 2024 and is projected to reach approximately USD 99.44 billion by 2034, expanding at a CAGR of 31.34% between 2025 and 2034. North America dominated the global clear aligners market in 2024.
• Dental CAD/CAM Systems: The global dental CAD/CAM market size was valued at USD 2.81 billion in 2024 and is predicted to increase from USD 3.10 billion in 2025 to approximately USD 7.48 billion by 2034, expanding at a CAGR of 10.29% from 2025 to 2034. North America led the market with the biggest market share in 2024.
• Dental Imaging Systems: The global dental imaging market size was valued at USD 4.79 billion in 2024 and is expected to hit USD 11.62 billion by 2034, growing at a CAGR of 9.27% from 2025 to 2034. North America dominated the dental imaging market in 2024.

Dentsply Sirona (XRAY) is focusing on several key initiatives to drive future revenue growth over the next two to three years, primarily encapsulated in its "Return to Growth" action plan. This comprehensive strategy aims for sustained profitable growth.

The expected drivers of future revenue growth include:

1. Enhanced Innovation through Increased R&D and New Product Launches: Dentsply Sirona is making targeted investments in research and development, pulling forward R&D investments to strengthen its position for 2026 and beyond, with a goal to reach 6% to 7% R&D investment. This focus on innovation is intended to accelerate growth momentum, launch new products, and add value to clinicians' workflows. The company also aims to shape the future of its markets by migrating from product offerings to proceduralization, leveraging its broad portfolio.
2. Strategic Focus on the U.S. Market and Customer Experience: A significant part of the "Return to Growth" plan involves reigniting growth in the U.S. market, which has experienced sales declines. The company plans to restructure commercial operations, particularly in the U.S., and enhance customer engagement and experience to address these challenges.
3. Growth of Key Product Segments, particularly Wellspect and SureSmile: The Wellspect Healthcare business has shown strong performance, with significant growth in both the U.S. and Europe, and is expected to continue driving growth. Similarly, the SureSmile clear aligner segment is anticipated to contribute to growth, with notable expansion in regions like Europe and market share gains in clear aligners.
4. Operational Efficiency and Organizational Strengthening: Dentsply Sirona is focusing on streamlining operations, strengthening its organizational foundation, and enhancing its enterprise AI and automation strategy. These initiatives are aimed at improving overall performance, freeing up capital for growth initiatives, and contributing to sustainable and profitable growth.

Share Repurchases

• In November 2023, Dentsply Sirona's Board of Directors approved a $1.0 billion increase to its authorized share repurchase program.
• As of December 31, 2024, the company had $1.2 billion remaining under this share repurchase authorization.
• For the year ended December 31, 2024, Dentsply Sirona repurchased approximately 9.4 million shares at a cost of $250 million.

Outbound Investments

• In fiscal year 2020, Dentsply Sirona made cash acquisitions totaling $1,078 million.
• The company made cash acquisitions of $248 million in fiscal year 2021.

Capital Expenditures

• Dentsply Sirona estimates capital expenditures for the full year 2025 to be in the range of approximately $130 million to $140 million.
• These investments are primarily focused on the ongoing implementation of a new global ERP system, equipment upgrades, and capacity expansion to support product innovation and consolidate operations.
• Historical capital expenditures were approximately $180 million in fiscal year 2024, $149 million in fiscal year 2023, and $149 million in fiscal year 2022.